World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
29733
World Ranking
967
National Ranking
444

Medicine

D-Index
86
Citations
34270
World Ranking
13945
National Ranking
7077

Kenneth V. I. Rolston publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kenneth V. I. Rolston sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 369 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kenneth V. I. Rolston D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth V. I. Rolston sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kenneth V. I. Rolston is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on infections related to cancer patients, antibiotic resistance, and bacterial pathogens within clinical settings.

The scientist's work covers multiple main fields of study, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Rolston has contributed to several subfields such as:

  • Oncology
  • Epidemiology
  • Molecular Medicine
  • Pharmacology
  • Clinical Biochemistry

Their research extensively addresses the following main topics:

  • Neutropenia and Cancer Infections
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Oral health in cancer treatment
  • Hematological disorders and diagnostics

Kenneth V. I. Rolston has published in a variety of academic venues, including:

  • JAC-Antimicrobial Resistance
  • Infectious Diseases and Therapy
  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • Infectious Diseases

Some recent papers authored or co-authored by Rolston include:

  • Activity of Cefiderocol and Comparators against Isolates from Cancer Patients, 2020, Antimicrobial Agents and Chemotherapy
  • In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer, 2023, JAC-Antimicrobial Resistance

Other notable papers relevant to Rolston's research interests include:

  • Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options, 2022, Infectious Diseases and Therapy
  • Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?, 2022, Open Forum Infectious Diseases
  • Infections in Patients with Cancer, 2022, Holland-Frei Cancer Medicine

Their frequent co-authors consist of:

  • Samuel A. Shelburne
  • Issam Raad
  • Randall A. Prince
  • Lior Nesher
  • Bahgat Gerges

Best Publications

  • Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Alison G. Freifeld;Eric J. Bow;Kent A. Sepkowitz;Michael J. Boeckh

  • 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

    Walter T. Hughes;Donald Armstrong;Gerald P. Bodey;Eric J. Bow

  • The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

    Jean Klastersky;Marianne Paesmans;Edward B. Rubenstein;Michael Boyer

  • 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

    Walter T. Hughes;Donald Armstrong;Gerald P. Bodey;Arthur E. Brown

  • Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

    Jean Klastersky;J. de Naurois;Kenneth Rolston;Bernardo Leon B. Rapoport

  • Zygomycosis in the 1990s in a Tertiary-Care Cancer Center

    Dimitrios P. Kontoyiannis;Verena C. Wessel;Gerald P. Bodey;Kenneth V. I. Rolston

  • The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

    Daniel J. Diekema;Po Ren Hsueh;Rodrigo E. Mendes;Michael A. Pfaller

  • Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Alison G. Freifeld;Eric J. Bow;Kent A. Sepkowitz;Michael J. Boeckh

  • Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

    Christopher R. Flowers;Jerome Seidenfeld;Eric J. Bow;Clare Karten

  • Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

    Randy A Taplitz;Erin B Kennedy;Eric J Bow;Jennie Crews

  • Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials

    Linda S. Elting;Edward B. Rubenstein;Kenneth V. I. Rolston;Gerald P. Bodey

  • Prevention and treatment of cancer-related infections, version 2.2016

    Lindsey Robert Baden;Sankar Swaminathan;Michael Angarone;Gayle Blouin

  • Bacteraemia in febrile neutropenic cancer patients

    Jean Klastersky;Lieveke Ameye;J. Maertens;Aspasia Georgala

  • Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

    Edward B. Rubenstein;Kenneth Rolston;Carmelita P Escalante;Ellen F Manzullo

  • Adenovirus Infections in Adult Recipients of Blood and Marrow Transplants

    Alberto M. La Rosa;Richard E. Champlin;Nadeem Mirza;James Gajewski

  • Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update

    Randy A. Taplitz;Erin B. Kennedy;Eric J. Bow;Jennie Crews

  • Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.

    Nikolaos V. Sipsas;Russell E. Lewis;Jeffrey Tarrand;Ray Hachem

  • New spectrum of fungal infections in patients with cancer.

    Elias Anaissie;Gerald P. Bodey;Hagop M Kantarjian;Jae Ro

  • Staphylococcus epidermidis: Emerging Resistance and Need for Alternative Agents

    Issam Raad;Amin Alrahwan;Kenneth Rolston

  • Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.

    Ioannis Chatzinikolaou;Ioannis Chatzinikolaou;Dima Abi-Said;Gerald P. Bodey;Kenneth V. I. Rolston

  • Prevention and treatment of cancer-related infections

    Lindsey Robert Baden;William Bensinger;Michael Angarone;Corey Casper

Frequent Co-Authors

Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Issam I Raad
Issam I Raad The University of Texas MD Anderson Cancer Center
Jeffrey J Tarrand
Jeffrey J Tarrand The University of Texas MD Anderson Cancer Center
Linda S. Elting
Linda S. Elting The University of Texas MD Anderson Cancer Center
Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
Pranatharthi H. Chandrasekar
Pranatharthi H. Chandrasekar Wayne State University
Ray Y Hachem
Ray Y Hachem The University of Texas MD Anderson Cancer Center
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Victor Fainstein
Victor Fainstein Houston Methodist
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers related to microbiology often involves considering diverse educational paths. For those interested in public health, pursuing mph online programs with easy admission requirements can be a practical choice, offering accessibility while preparing graduates for roles in disease prevention and health promotion.

Another fulfilling career path connected to health sciences is becoming a child life specialist. This role focuses on helping children and families cope with medical experiences, blending knowledge of psychology and healthcare, which can complement a background in microbiology.

For individuals with unique challenges, such as those seeking the best associate degrees for felons, there are online degree options that can open doors to new career opportunities in science and healthcare fields, highlighting the importance of accessible education.

Additionally, careers like a functional medicine nurse practitioner may appeal to microbiology graduates interested in clinical roles. Understanding the earnings of a functional medicine np salary can help guide decisions about this specialized healthcare pathway.

Best Scientists Citing Kenneth V. I. Rolston

Trending Scientists

Recently Published Articles